(Circulation. 1998;98:378-379.)
© 1998 American Heart Association, Inc.
Phentolamine and Preconditioning During Coronary Angioplasty
Ali Dana, BSc, MRCP;
Jun-ichi Imagawa, PhD;
; Derek M Yellon, PhD, DSc, FESC, FACC
The Hatter Institute of Cardiology,
UCL Hospitals & Medical School,
London, UK
To the Editor:
We read with great interest the article by Tomai et
al1 on the role of
-adrenergic receptors in
ischemic preconditioning during coronary angioplasty.
They provide evidence that pretreatment with phentolamine, a
nonselective
-adrenoceptor blocking agent, abolishes the adaptation
to myocardial ischemia during sequential coronary
balloon inflations. The authors conclude a role for
-adrenergic
receptors in mediating ischemic preconditioning in this model.
This work extends previous work by the same group implicating a role
for adenosine A1
receptors2 and the ATP-sensitive potassium
channels (KATP)3 in
ischemic preconditioning using the same model.
What the authors fail to mention in their discussion is the fact
that phentolamine, independent of its
-blocking properties,
has been shown to block KATP channels in
insulin-producing cells,4 in
vascular5 and nonvascular smooth muscle
cells,6 and more recently, in cardiac
ventricular myocytes.7 The
involvement of KATP channels in the mechanism of
ischemic preconditioning has been demonstrated in a number of
animal models,8 as well as in isolated human
atrial trabeculae.9 10 Furthermore,
Tomai et al3 have previously shown that blockade
of KATP channels abolishes the myocardial
adaptation observed during sequential coronary balloon
inflations. It is therefore not possible to draw any conclusions about
the exact mode of action of phentolamine and consequently about
the mechanisms of ischemic preconditioning during
coronary angioplasty from the presented
data.1 Although, as the authors suggest, the
-blocking properties of phentolamine may be responsible for
the loss of adaptation to ischemia, their observations can also
be explained by blockade of KATP channels . . . [Full Text of this Article]
Fabrizio Tomai, MD, FESC;
Filippo Crea, MD, FACC, FESC;
Achille Gaspardone, MD, FESC;
; Pier A. Gioffrè, MD, FESC
Divisione di Cardiochirurgia,
Università di Roma Tor Vergata,
European Hospital,
Rome, Italy
This article has been cited by other articles:

|
 |

|
 |
 
E. M. Carvalho, E. A Gabriel, and T. A Salerno
Pulmonary Protection During Cardiac Surgery: Systematic Literature Review
Asian Cardiovasc Thorac Ann,
December 1, 2008;
16(6):
503 - 507.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Huang, T. Yao, W. Wang, D. Zhu, W. Zhang, H. Chen, and W. Fu
Continuous ultrafiltration attenuates the pulmonary injury that follows open heart surgery with cardiopulmonary bypass
Ann. Thorac. Surg.,
July 1, 2003;
76(1):
136 - 140.
[Abstract]
[Full Text]
[PDF]
|
 |
|